simvastatin has been researched along with Depression, Involutional in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, F; Ansari, MA; Chaudhry, IB; Chaudhry, N; Hodsoll, J; Husain, MI; Husain, MO; Husain, N; Khan, HA; Khan, N; Khoso, AB; Kiran, T; Meyer, JH; Minhas, F; Mulsant, BH; Naqvi, HA; Nizami, AT; Young, AH | 1 |
| Chae, WR; Ettrich, B; Friede, T; Gold, SM; Grabe, HJ; Hegerl, U; Hinkelmann, K; Hofmann, T; Janowitz, D; Junghanns, K; Kaczmarczyk, M; Kahl, KG; Klein, JP; Krueger, THC; Leicht, G; Lischewski, S; Märschenz, S; Nowacki, J; Otte, C; Piber, D; Prvulovic, D; Reif, A; Roepke, S; Schmidt, S; Schoettle, D; Strauss, M; Westermair, A | 1 |
| Davison, KM; Kaplan, BJ | 1 |
| Akhondzadeh, S; Farokhnia, M; Gougol, A; Iranpour, N; Raheb, S; Salimi, S; Yekehtaz, H; Zareh-Mohammadi, N | 1 |
| Berk, M; Brownstein, DJ; Dodd, S; Fernandes, BS; Salagre, E | 1 |
| Berk, M; Henry, MJ; Jacka, FN; Kotowicz, MA; Nicholson, GC; Pasco, JA; Williams, LJ | 1 |
| Tobe, E | 1 |
| Ceska, R; Fisar, Z; Kvasnicka, T; Papezová, H; Stárková, L; Vevera, J; Zdenek, H | 1 |
1 review(s) available for simvastatin and Depression, Involutional
| Article | Year |
|---|---|
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Topics: Antidepressive Agents; Atorvastatin; Citalopram; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2016 |
3 trial(s) available for simvastatin and Depression, Involutional
| Article | Year |
|---|---|
Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Topics: Adult; Antidepressive Agents; C-Reactive Protein; Depression; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lipids; Male; Simvastatin | 2023 |
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Berlin; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Multicenter Studies as Topic; Obesity; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2020 |
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.
Topics: Adult; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Severity of Illness Index; Simvastatin; Treatment Outcome; Young Adult | 2015 |
4 other study(ies) available for simvastatin and Depression, Involutional
| Article | Year |
|---|---|
Lipophilic statin use and suicidal ideation in a sample of adults with mood disorders.
Topics: Adult; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder; Depressive Disorder, Major; Dietary Fats; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Risk Factors; Simvastatin; Suicidal Ideation | 2014 |
Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.
Topics: Aspirin; Atorvastatin; Case-Control Studies; Confidence Intervals; Cytokines; Depressive Disorder, Major; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Middle Aged; Models, Psychological; Pravastatin; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors | 2010 |
Pseudodementia caused by severe depression.
Topics: Aged; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder, Major; Diagnosis, Differential; Factitious Disorders; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Simvastatin | 2012 |
Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission.
Topics: Adult; Anticholesteremic Agents; Blood Platelets; Cholesterol; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorescence Polarization; Humans; Hypercholesterolemia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Serotonin Plasma Membrane Transport Proteins; Simvastatin; Time Factors | 2005 |